"True Cell Type","Predicted Main Cell Type","Predicted Sub Cell Types","Possible Mixed Cell Types","Marker Number","Marker List","Iterations","Model","Provider","Tissue","Species","Additional Info","Conversation History"
"cd8-positive, alpha-beta t cell","Cytotoxic T Lymphocytes (CTLs)","Activated CD8+ Effector T cells, Activated CD8+ Effector Memory T cells, Cytotoxic Gamma-Delta (γδ) T cells","CD8+ Effector/Effector Memory T cells with NK-like phenotype, Cytotoxic Gamma-Delta (γδ) T cells, NK cells (minor contribution/overlap)","50","KLRC2, XCL2, LINC02446, CRTAM, KLRK1, KLRC4, KLRD1, XCL1, GZMH, CD160, CD8B, NKG7, GZMA, GZMB, GZMK, CD8A, TRGC2, SLA2, TIGIT, TNFRSF9, GPR18, CCL4, PRF1, ATP8B4, APBA2, CCL4L2, DUSP4, CTSW, TMIGD2, TRGC1, CCL5, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, GZMM, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2","1","google/gemini-2.5-flash","openrouter","peripheral_blood","human","Batch analysis via web interface","Final Annotation Agent: As a professional computational biologist, I will now proceed with a comprehensive analysis to identify the cell type based on the provided ranked marker list from a human peripheral blood single-cell dataset. **Step 1: Analyze Marker Genes** I will examine the provided ranked marker list, paying close attention to known markers and their typical expression patterns in peripheral blood cells. * **KLRC2, KLRK1 (NKG2D), KLRC4, KLRD1 (CD94):** These are classic markers for Natural Killer (NK) cells and certain subsets of T cells, particularly CD8+ T cells. They are part of the Killer Cell Lectin-like Receptor (KLR) family. * **XCL2, XCL1:** These are chemokines (lymphotactin family) often associated with NK cells and cytotoxic T lymphocytes. * **CRTAM:** Class I-restricted T cell-associated molecule. Expressed on NK cells and cytotoxic T cells, involved in cell adhesion and activation. * **CD160:** A receptor expressed on NK cells, CD8+ T cells, and γδ T cells, involved in cytotoxicity. * **CD8B, CD8A:** Coreceptors defining cytotoxic T lymphocytes (CTLs). CD8A and CD8B form the CD8 heterodimer. Their presence is a strong indicator of CD8+ T cells. * **NKG7:** Natural killer cell granule protein 7. Found in cytotoxic granules of NK cells and CTLs. * **GZMH, GZMA, GZMB, GZMK, GZMM:** Granzymes. These are serine proteases found in the granules of cytotoxic lymphocytes (NK cells and CTLs) and are crucial for inducing target cell apoptosis. Their high expression is a hallmark of cytotoxic activity. * **TRGC2, TRGC1:** T cell receptor gamma constant 2 and 1. These are components of the T cell receptor (TCR) found on gamma-delta (γδ) T cells. Their presence suggests a γδ T cell component. * **SLA2:** SH2D1A-like adaptor protein 2. Involved in NK cell and T cell signaling. * **TIGIT:** T cell immunoreceptor with Ig and ITIM domains. An inhibitory receptor expressed on NK cells, T cells (especially regulatory T cells and exhausted T cells), and B cells. Its presence here, alongside cytotoxic markers, might indicate an activated or potentially exhausted cytotoxic population. * **TNFRSF9 (CD137/4-1BB):** Tumor necrosis factor receptor superfamily member 9. A costimulatory molecule expressed on activated T cells (CD8+ and CD4+), NK cells, and other immune cells. Indicates activation. * **GPR18:** G protein-coupled receptor 18. Expressed on various immune cells, including T cells and NK cells. * **CCL4, CCL4L2, CCL5:** Chemokine (C-C motif) ligand 4, 4-like 2, and 5 (RANTES). These are potent chemoattractants produced by various immune cells, including activated T cells and NK cells, involved in immune cell recruitment. * **PRF1 (Perforin 1):** A pore-forming protein crucial for the cytotoxic activity of NK cells and CTLs. Its high expression is a definitive marker of cytotoxic lymphocytes. * **ATP8B4, APBA2, DUSP4, CTSW, TMIGD2, ABI3, IL21R, IFNG, CD7, CLIC3, ENTPD1, LDLRAD4, PTPN22, HOPX, CST7, PARD6G, ZEB2, SH2D1A, LAYN, LAG3, PRKCH, AOAH, IKZF2:** While some of these are more general immune cell markers or involved in various cellular processes, others are notable: * **IFNG (Interferon-gamma):** A key cytokine produced by activated T cells (Th1, CD8+) and NK cells, central to antiviral and anti-tumor immunity. Its presence strongly supports an activated cytotoxic population. * **CD7:** A pan-T cell marker, also expressed on NK cells. * **SH2D1A (SAP):** Signaling lymphocyte activation molecule associated protein. Crucial for NK cell and T cell function, particularly in X-linked lymphoproliferative disease. * **LAG3:** Lymphocyte-activation gene 3. An inhibitory receptor expressed on activated T cells (CD4+, CD8+), NK cells, and regulatory T cells, often associated with T cell exhaustion. **Summary of Marker Gene Analysis:** The list is overwhelmingly dominated by genes associated with **cytotoxicity** and **lymphocyte activation**. Key markers include: * **Cytotoxic machinery:** PRF1, GZMA, GZMB, GZMH, GZMK, GZMM, NKG7. * **T cell lineage:** CD8A, CD8B, CD7, TRGC1, TRGC2. * **NK cell lineage:** KLRC2, KLRK1, KLRC4, KLRD1, CD160. * **Activation/Effector function:** IFNG, CCL4, CCL5, TNFRSF9, CRTAM. * **Inhibitory receptors (often co-expressed on activated/exhausted cells):** TIGIT, LAG3. The co-expression of CD8A/B with NK cell receptors (KLRs, CD160) and γδ TCR components (TRGC1/2) is particularly interesting. This suggests either a mixed population or a specific subset of T cells that share features with NK cells, such as NK-like T cells or NKT cells, or highly activated cytotoxic T cells that upregulate NK receptors. However, the sheer number and high ranking of granzymes and perforin strongly point to a cytotoxic effector population. **Step 2: Consider Biological Context** The sample is from **human peripheral blood**. This context is crucial as it limits the possible cell types to those circulating in the bloodstream. Peripheral blood contains various immune cells, including T cells (CD4+, ... [truncated]"
"intestinal crypt stem cell","Circulating Tumor Cells (CTCs)","Cancer Stem Cell-like (CSC-like)","","50","AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491.1, AC022968.1","2","google/gemini-2.5-flash","openrouter","peripheral_blood","human","Batch analysis via web interface","Final Annotation Agent: As a professional computational biologist, I will now proceed with the step-by-step analysis to identify the cell type based on the provided ranked marker list from a human peripheral blood single-cell dataset. **Step 1: Analyze Marker Genes** The provided list of markers is: AL031284.1, AC012085.1, IGFBPL1, HMGN2P6, CHCHD2P9, PPIAP40, LGR5, RPL7P54, AC010132.3, EIF5AP4, AC008694.2, COX5AP2, TDGF1, ASCL2, AC092670.1, NPM1P6, PPIAP11, AC090498.1, RPL41P1, CYCSP55, HMGN2P4, TPI1P1, RPL41P5, AL162151.2, PPIAP29, HNRNPA1P4, AC016596.2, AL603825.1, RPL9P21, AC005884.2, PPIAP31, HMGN1P36, HMGN2P41, AL035411.1, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, SLC39A2, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, AF279873.1, RPL7P6, AC112491, AC022968.1. Upon initial inspection, a significant portion of the listed """"markers"""" are either: * **LncRNAs/Non-coding RNAs:** Many entries starting with """"AC"""", """"AL"""", or ending with """".1"""" or """".2"""" are likely uncharacterized or poorly characterized non-coding RNAs or genomic loci. These are generally not reliable cell type markers unless specifically validated. * **Pseudogenes:** Many entries ending with """"P"""" followed by numbers (e.g., HMGN2P6, CHCHD2P9, PPIAP40, RPL7P54, NPM1P6, RPL41P1, CYCSP55, TPI1P1, RPL41P5, PPIAP29, HNRNPA1P4, RPL9P21, PPIAP31, HMGN1P36, HMGN2P41, RPS26P39, FABP5P7, SDHDP6, ATP5PFP1, EEF1A1P5, RPSAP8, HMGN2P3, KRT8P13, RPL21P16, RPSAP15, HMGN1P38, RPL7P6) are clearly pseudogenes. Pseudogenes are typically non-functional copies of genes and their expression is often low, noisy, or not directly indicative of cell function or identity. Their presence in a """"highly expressed marker"""" list is unusual and suggests potential issues with the gene annotation or quantification pipeline, or that these pseudogenes are indeed expressed, but their biological relevance as cell type markers is questionable. Let's focus on the protein-coding genes that are known and potentially informative: * **IGFBPL1 (Insulin Like Growth Factor Binding Protein Like 1):** While IGFBPs are involved in various cellular processes, IGFBPL1 itself is not a highly specific or canonical marker for a particular immune cell type in peripheral blood. It has been implicated in various cancers and developmental processes. * **LGR5 (Leucine Rich Repeat Containing G Protein-Coupled Receptor 5):** LGR5 is a well-known marker for adult stem cells in various tissues, particularly in the intestine, hair follicle, and kidney. Its presence in peripheral blood is highly unusual for a typical immune cell type. If expressed, it might indicate a very rare circulating progenitor cell or a non-hematopoietic contaminant, or perhaps a technical artifact. * **TDGF1 (Teratocarcinoma-Derived Growth Factor 1, also known as Cripto):** TDGF1 is a member of the EGF-CFC family of proteins, involved in embryonic development and stem cell maintenance. Like LGR5, its expression in peripheral blood immune cells is highly unexpected and would typically point towards embryonic-like cells, cancer cells, or very rare progenitor populations. * **ASCL2 (Achaete-Scute Family BHLH Transcription Factor 2):** ASCL2 is a transcription factor primarily known for its role in intestinal stem cell maintenance and neuroendocrine differentiation. Its presence in peripheral blood is also highly atypical for common immune cell types. * **SLC39A2 (Solute Carrier Family 39 Member 2, also known as ZIP2):** This gene encodes a zinc transporter. While zinc transport is ubiquitous, SLC39A2 itself is not a specific marker for any particular immune cell type. **Summary of Marker Analysis:** The vast majority of the """"markers"""" are either uncharacterized non-coding RNAs, pseudogenes, or genes (IGFBPL1, LGR5, TDGF1, ASCL2) that are *not* typically expressed in common peripheral blood immune cells. LGR5, TDGF1, and ASCL2 are strong markers for stem/progenitor cells or specific epithelial/developmental lineages, which are not expected to be abundant in peripheral blood. The presence of so many pseudogenes and uncharacterized non-coding RNAs at the top of a """"highly expressed marker"""" list is a significant red flag. **Step 2: Consider Biological Context** * **Tissue Type:** Human Peripheral Blood. This context primarily contains various types of immune cells (T cells, B cells, NK cells, monocytes, neutrophils, dendritic cells, etc.) and red blood cells (though scRNA-seq typically depletes these). * **Species:** Human. * **Biological Plausibility:** The presence of LGR5, TDGF1, and ASCL2 as top markers is highly implausible for any *common* peripheral blood immune cell type. These genes are characteristic of stem cells, developmental lineages, or certain cancer cells. **Step 3: Formulate Hypotheses** Given the highly unusual marker list, especially the prevalence of pseudogenes and genes not typically found in peripheral blood immune cells, I must consider several possibilities, including technical artifacts. 1. **Hypot... [truncated]"
"intestinal enteroendocrine cell","Neuroendocrine Cells","Alpha-cell like (pancreatic islet), Enteroendocrine-like (L-cell, EC-cell)","Circulating Neuroendocrine Tumor Cells (CTCs), Contaminating Neuroendocrine Tissue","50","GCG, PCSK1, AC090679.1, UCN3, PYY, INSL5, CHGA, LCN15, SCG2, FEV, CPLX2, NKX2-2, AL133325.3, C1orf127, LINC01014, SCGN, SLC18A1, SCG3, SCG5, TPH1, MARCH4, INSM1, RTN1, CRYBA2, SNAP25, CHGB, CRMP1, KCNB2, RFX6, AMER3, SLC32A1, CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8, RIMBP2, AL161658.1, COL2A1, CELF3, SCT, RIIAD1, SSTR5-AS1, RGS4, ARX, PRPH, INA, F5, AP003062.3, SLC5A8","1","google/gemini-2.5-flash","openrouter","peripheral_blood","human","Batch analysis via web interface","Final Annotation Agent: As a professional computational biologist, I will now proceed with a comprehensive analysis to identify the cell type based on the provided ranked marker list from a human peripheral blood single-cell dataset. **Step 1: Analyze Marker Genes** I will examine the provided ranked marker list, focusing on the top markers as they represent the highest expression intensity. * **GCG (Glucagon):** A well-known hormone primarily produced by alpha cells of the pancreatic islets. Its presence in peripheral blood cells is highly unusual for typical immune or blood cell types. * **PCSK1 (Proprotein Convertase Subtilisin/Kexin Type 1):** Involved in the proteolytic processing of prohormones and proneuropeptides, including proglucagon. Highly expressed in neuroendocrine cells. * **AC090679.1, UCN3 (Urocortin 3), PYY (Peptide YY), INSL5 (Insulin-like 5), CHGA (Chromogranin A):** These are all strong markers for neuroendocrine cells. UCN3 is found in pancreatic islet cells (beta and alpha cells), PYY in enteroendocrine L-cells, and INSL5 in enteroendocrine L-cells. CHGA is a general marker for neuroendocrine cells. * **LCN15, SCG2 (Secretogranin II), FEV, CPLX2 (Complexin 2), NKX2-2 (NK2 Homeobox 2):** These further reinforce the neuroendocrine signature. NKX2-2 is a transcription factor crucial for pancreatic islet development and neuroendocrine differentiation. * **AL133325.3, C1orf127, LINC01014, SCGN (Secretagogin), SLC18A1 (Solute Carrier Family 18 Member A1 - Vesicular Monoamine Transporter 1, VMAT1), SCG3 (Secretogranin III), SCG5 (Secretogranin V):** More markers consistent with neuroendocrine cells, particularly those involved in hormone/neurotransmitter storage and secretion. SCGN is a calcium-binding protein found in neuroendocrine cells. SLC18A1 is involved in packaging monoamines into synaptic vesicles. * **TPH1 (Tryptophan Hydroxylase 1):** Rate-limiting enzyme in serotonin synthesis, found in enterochromaffin cells (a type of enteroendocrine cell). * **MARCH4, INSM1 (Insulinoma-associated 1):** INSM1 is a key transcription factor for neuroendocrine differentiation. * **RTN1, CRYBA2, SNAP25 (Synaptosomal-Associated Protein 25), CHGB (Chromogranin B), CRMP1, KCNB2, RFX6 (Regulatory Factor X6), AMER3, SLC32A1 (Solute Carrier Family 32 Member A1 - Vesicular GABA Transporter, VGAT):** SNAP25 is a core component of the SNARE complex, essential for neurotransmitter/hormone release in neurons and neuroendocrine cells. RFX6 is a transcription factor critical for pancreatic islet cell development. SLC32A1 is involved in GABA transport, suggesting a neuroendocrine or neuronal lineage. * **CDK5R2, AVPR1B, VWA5B2, AC022893.2, ABCC8 (ATP Binding Cassette Subfamily C Member 8), RIMBP2, AL161658.1, COL2A1, CELF3, SCT (Secretin), RIIAD1, SSTR5-AS1, RGS4, ARX (Aristaless Related Homeobox), PRPH (Peripherin), INA (Internexin Alpha), F5, AP003062.3, SLC5A8:** ABCC8 is part of the KATP channel, crucial for insulin secretion in pancreatic beta cells. SCT is a hormone produced by S cells in the duodenum. ARX is a transcription factor involved in pancreatic alpha cell development and neuronal differentiation. PRPH and INA are intermediate filament proteins found in neurons and neuroendocrine cells. **Summary of Marker Analysis:** The overwhelming majority of the highly expressed markers are classic indicators of neuroendocrine cells. Specifically, there's a strong enrichment for markers associated with pancreatic islet cells (GCG, PCSK1, NKX2-2, ABCC8, RFX6, ARX) and enteroendocrine cells (PYY, INSL5, TPH1, SCT). General neuroendocrine markers like CHGA, CHGB, SCG2, SCGN, SNAP25, INSM1, PRPH, and INA are also prominent. **Step 2: Consider Biological Context** * **Tissue Type: Peripheral Blood.** This is the critical piece of information. Typical peripheral blood contains immune cells (lymphocytes, monocytes, granulocytes), red blood cells, and platelets. It does *not* normally contain significant numbers of intact, functional neuroendocrine cells from organs like the pancreas or gut. * **Species: Human.** * **Additional Information: """"Batch analysis via web interface.""""** This suggests a standard scRNA-seq pipeline. The presence of such a strong neuroendocrine signature in a *peripheral blood* sample is highly anomalous. This immediately raises several possibilities: 1. **Contamination:** The sample might be contaminated with cells from another tissue (e.g., pancreatic tissue, gut tissue, or a neuroendocrine tumor). 2. **Circulating Tumor Cells (CTCs):** The patient might have a neuroendocrine tumor (e.g., pancreatic neuroendocrine tumor, carcinoid tumor) that is shedding cells into the bloodstream. These CTCs would express the markers of their tissue of origin. 3. **Rare Circulating Neuroendocrine Cells (Non-Malignant):** While extremely rare, some studies have reported the presence of very low numbers of non-malignant circulating cells from various organs. However, the high expression of these markers sugge... [truncated]"
"monocyte","Contaminating Neural Cells","Schwann cells, Oligodendrocytes","Natural Killer (NK) cells (minor component/ambient RNA), Circulating Neural Tumor Cells","50","NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, AL136298.1, SFRP5, Z97205.2, AL358216.1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, LINC01436, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, Z95114.1, RHAG, FOXD3-AS1, BMS1P10, FAM19A5, FGFBP2","2","google/gemini-2.5-flash","openrouter","peripheral_blood","human","Batch analysis via web interface","Final Annotation Agent: As a professional computational biologist, I will now proceed with the step-by-step analysis to identify the cell type based on the provided ranked marker list from a human peripheral blood single-cell dataset. **Step 1: Analyze Marker Genes** I will examine the provided ranked marker list, focusing on genes with established roles in cell type identification, particularly in the context of peripheral blood. * **NKAIN3, SPP1, CDH19, TSPAN11, PLP1, L1CAM, MYOT, IGSF11, NRXN1, SLC35F1, SOX10, MEGF10, SYT10, CADM2, SLITRK2, SOX2, CRTAC1, CHL1, ZNF536, FOXD3, PTPRZ1, GRIK3, TUBB2B, CMTM5, TTYH1, ADARB2, CDH2, TENM3, WNT6, ATP1A2, NRXN3, KCNMB4, TMEM132B, LPL, GFRA2, CHADL, FLRT1, CHST9, GJC3, RHAG, FOXD3-AS1, FAM19A5, FGFBP2:** * **PLP1 (Proteolipid Protein 1):** A major component of myelin in the central and peripheral nervous systems. Highly specific for oligodendrocytes and Schwann cells. * **L1CAM (L1 Cell Adhesion Molecule):** Involved in neuron-neuron adhesion, neurite outgrowth, and myelination. Expressed by neurons and Schwann cells. * **NRXN1 (Neurexin 1), NRXN3 (Neurexin 3):** Presynaptic cell adhesion molecules crucial for synapse formation and function. Primarily neuronal. * **SOX10 (SRY-Box Transcription Factor 10):** A key transcription factor for neural crest development, essential for the development and maintenance of Schwann cells, oligodendrocytes, and melanocytes. * **SOX2 (SRY-Box Transcription Factor 2):** Involved in maintaining pluripotency and neural stem cell identity. Expressed in neural stem cells, neurons, and glia. * **FOXD3 (Forkhead Box D3):** A transcription factor involved in neural crest development, pluripotency, and cell fate decisions. Expressed in neural crest derivatives, including melanocytes and Schwann cells. * **PTPRZ1 (Protein Tyrosine Phosphatase Receptor Type Z1):** Expressed in the nervous system, particularly in glial cells and neurons. * **TUBB2B (Tubulin Beta 2B):** A beta-tubulin isoform primarily expressed in neurons. * **CDH2 (Cadherin 2, N-cadherin):** Involved in cell-cell adhesion, prominent in neural tissues. * **TMEM132B (Transmembrane Protein 132B):** Implicated in neuronal function and psychiatric disorders. * **GFRA2 (GDNF Family Receptor Alpha 2):** A receptor for GDNF family ligands, involved in neuronal survival and differentiation. * **CHL1 (Cell Adhesion Molecule L1 Like):** A neural cell adhesion molecule. * **SPP1 (Secreted Phosphoprotein 1, Osteopontin):** While often associated with macrophages/immune cells in inflammation, its co-expression with neural markers here is notable. It can be expressed by some neural cell types or in response to neural injury. * **MYOT (Myotilin):** Primarily associated with muscle, but its presence here is unusual for peripheral blood. Could indicate a rare cell type or contamination, or a non-canonical expression. * **LPL (Lipoprotein Lipase):** While expressed in various tissues, including adipocytes and muscle, its presence in this context needs careful consideration. * **FGFBP2 (FGF Binding Protein 2):** Often associated with NK cells in peripheral blood. Its presence here is a strong indicator of an immune cell type. **Initial Observations:** The most striking feature of this marker list is the overwhelming presence of genes typically associated with the **nervous system**, specifically **glial cells (Schwann cells, oligodendrocytes)** and **neurons**. Genes like PLP1, L1CAM, SOX10, NRXN1, NRXN3, SOX2, FOXD3, PTPRZ1, TUBB2B, CDH2, TMEM132B, GFRA2, and CHL1 are canonical markers for these cell types. However, the dataset is stated to be from **peripheral blood**. This presents a significant contradiction. Mature neurons and oligodendrocytes are not typically found in peripheral blood. Schwann cells are found in the peripheral nervous system, not circulating in blood. The presence of **FGFBP2** is a strong indicator of **Natural Killer (NK) cells** in peripheral blood. SPP1 can be expressed by various immune cells, including macrophages and some T cells, but also by some neural cells. **Step 2: Consider Biological Context** * **Tissue Type: Peripheral Blood (Human)**. This is the critical piece of information. Mature neural cells (neurons, oligodendrocytes, Schwann cells) are *not* circulating in healthy peripheral blood. * **Species: Human**. * **Biological Plausibility:** The presence of such a high number of neural-specific markers in peripheral blood is highly unusual and suggests several possibilities: 1. **Contamination:** The sample might be contaminated with neural tissue during collection or processing. 2. **Rare Circulating Cells:** Extremely rare circulating neural progenitor cells or cells with neural-like features might exist, but the sheer number and specificity of markers make this less likely for a dominant cluster. 3. **Misannotation/Mislabeling of Sample Source:** The sample might not be peripheral blood, or the cluster might represent cells from a different tissue tha... [truncated]"
"plasma cell","Plasma Cell","Plasmablast, Circulating Plasma Cell, Short-lived Plasma Cell","","50","IGLL5, IGLV6-57, JCHAIN, FAM92B, IGLC3, IGLC2, IGHV3-7, IGKC, TNFRSF17, IGHG1, AC026369.3, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, MYL2, MZB1, IGHG3, IGHV3-74, IGHM, ANKRD36BP2, AMPD1, IGKV3-20, IGHA2, DERL3, AC104699.1, LINC02362, AL391056.1, LILRB4, CCL3, BMP6, UBE2QL1, LINC00309, AL133467.1, GPRC5D, FCRL5, DNAAF1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, CCR10, BFSP2, APOBEC3A, AC106897.1","1","google/gemini-2.5-flash","openrouter","peripheral_blood","human","Batch analysis via web interface","Final Annotation Agent: As a professional computational biologist, I will meticulously analyze the provided ranked marker list from a human peripheral blood single-cell dataset to identify the cell type. **Step 1: Analyze Marker Genes** I will examine the provided ranked marker list carefully, focusing on the most highly expressed genes first, as they are typically the most indicative. * **IGLL5, IGLV6-57, JCHAIN, IGLC3, IGLC2, IGHV3-7, IGKC, IGHG1, IGHV3-23, IGKV4-1, IGKV1-5, IGHA1, IGLV3-1, IGLV2-11, IGHG3, IGHM, IGKV3-20, IGHA2:** This is an overwhelming presence of immunoglobulin (Ig) genes, including light chain variable (IGLV, IGKV), light chain constant (IGLC, IGKC), heavy chain variable (IGHV), and heavy chain constant (IGHG, IGHM, IGHA) genes. The presence of JCHAIN (joining chain) is also highly significant. These genes are the hallmark of B-lineage cells, specifically those actively producing and secreting antibodies. * **TNFRSF17 (BCMA):** B-cell maturation antigen. This is a key marker for plasma cells and plasmablasts, involved in their survival and differentiation. * **MZB1 (Marginal zone B and B1 cell specific protein):** While its name suggests marginal zone B cells, MZB1 is also highly expressed in plasma cells and plasmablasts, playing a role in protein secretion. * **GPRC5D:** G protein-coupled receptor class C group 5 member D. This is a known surface marker highly expressed on plasma cells, particularly in multiple myeloma. * **FCRL5 (Fc receptor-like 5):** Also known as CD307e. Expressed on B cells and plasma cells, particularly those involved in immune responses. * **DERL3 (Derlin 3):** Involved in ER-associated degradation (ERAD), which is highly active in cells with extensive protein synthesis and secretion, like plasma cells. * **CCL3 (MIP-1α):** While not exclusive, some plasma cells can produce chemokines. * **LILRB4 (CD85k):** Leukocyte immunoglobulin-like receptor B4. Expressed on myeloid cells, but also found on some B cell subsets and plasma cells. Its presence here is less specific than the Ig genes or TNFRSF17. * **MYL2 (Myosin Light Chain 2):** Typically associated with muscle cells. Its presence here is unusual for a hematopoietic cell and might indicate a low-level, non-specific expression, or potentially a very minor contaminant, or a gene with a less characterized role in this specific cell type. Given the overwhelming Ig signature, it's likely a minor or non-specific hit. * **FAM92B, AC026369.3, ANKRD36BP2, AMPD1, AC104699.1, LINC02362, AL391056.1, LINC00309, AL133467.1, AP002852.1, AC007569.1, CXorf21, RNU1-85P, U62317.4, TXNDC5, LINC02384, BFSP2, APOBEC3A, AC106897.1:** Many of these are uncharacterized loci, lincRNAs, or genes with less specific roles in immune cells. Their high ranking suggests they are highly expressed in this specific cell state, but without known specific immune functions, they are less informative for initial cell type identification compared to the canonical markers. * **BMP6 (Bone Morphogenetic Protein 6):** While BMPs have diverse roles, including in hematopoiesis, BMP6 is not a primary marker for a specific immune cell type in peripheral blood. * **UBE2QL1, DNAAF1, CCR10:** Less specific markers in this context. CCR10 is a chemokine receptor, but not a primary identifier here. **Step 2: Consider Biological Context** * **Tissue Type: Peripheral Blood (Human)**. This context is crucial. Peripheral blood contains various immune cells (T cells, B cells, NK cells, monocytes, neutrophils, etc.) and their subsets. Mature plasma cells are typically found in lymphoid organs (bone marrow, lymph nodes, spleen) and mucosal tissues, but a small number of circulating plasmablasts/plasma cells can be found in peripheral blood, especially during active immune responses or in certain disease states. * **Species: Human.** This ensures that the gene names and their known functions are directly applicable. **Step 3: Formulate Hypotheses** Based on the strong evidence from Step 1 and considering the biological context: 1. **Hypothesis 1 (Most Likely): Plasma Cells / Plasmablasts.** The overwhelming expression of immunoglobulin genes (variable and constant regions for heavy and light chains), JCHAIN, TNFRSF17 (BCMA), MZB1, and GPRC5D are all highly characteristic of antibody-secreting cells. Plasmablasts are circulating precursors to plasma cells, and both are characterized by high Ig production. Given the peripheral blood context, these are likely circulating plasmablasts or short-lived plasma cells. 2. **Hypothesis 2 (Less Likely, but related): Activated B Cells.** While activated B cells do express Ig genes, the sheer volume and diversity of Ig chain expression, coupled with the presence of JCHAIN, TNFRSF17, MZB1, and GPRC5D, point more strongly towards a terminally differentiated, antibody-secreting cell state rather than a typical activated B cell. Activated B cells would typically also express higher levels of B cell receptor components (e.g., CD19, CD20... [truncated]"
"transit amplifying cell of large intestine","Proliferating Cells","Cells in S phase, Cells in G2 phase, Cells in M phase, Hematopoietic Stem and Progenitor Cells (HSPCs)","Activated Lymphocytes, Circulating Malignant Cells","50","HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2","1","google/gemini-2.5-flash","openrouter","peripheral_blood","human","Batch analysis via web interface","Final Annotation Agent: As a professional computational biologist, I will now proceed with a comprehensive analysis to identify the cell type based on the provided ranked marker list from a human peripheral blood single-cell dataset. **Step 1: Analyze Marker Genes** I will examine the provided ranked marker list, which is ordered by expression intensity from high to low. * **HJURP, UBE2C, CENPA, PBK, AURKB, DLGAP5, CKAP2L, KIF2C, KIF15, BIRC5, SPC25, ASPM, KIF18B, CEP55, DEPDC1, MKI67, CDC45, CDCA5, TOP2A, PCLAF, MND1, RRM2, ZNF695, CCNB2, NUF2, SKA3, SPC24, DTL, PKMYT1, CDCA3, TTK, DIAPH3, PLK1, IQGAP3, CDK1, TK1, POLQ, GTSE1, OIP5, FOXM1, TROAP, SKA1, NEK2, CDC25C, NCAPG, PIMREG, GINS2, RAD51AP1, CDT1, CCNA2** Upon initial inspection, a striking pattern emerges: the vast majority of these genes are well-established markers of cell proliferation and cell cycle progression. Let's break down some key markers: * **MKI67 (Ki-67):** This is a classic and highly reliable marker for proliferating cells. Its presence is almost always indicative of cells actively undergoing division. * **TOP2A (DNA Topoisomerase II Alpha):** Involved in DNA replication and chromosome segregation during mitosis. * **CDK1 (Cyclin-Dependent Kinase 1):** A master regulator of cell cycle progression, particularly entry into mitosis. * **CCNB2 (Cyclin B2), CCNA2 (Cyclin A2):** Cyclins are key regulators of CDK activity and cell cycle progression. * **AURKB (Aurora Kinase B):** Critical for chromosome segregation and cytokinesis. * **BIRC5 (Survivin):** An anti-apoptotic protein highly expressed in proliferating cells, involved in cell division. * **KIF2C, KIF15, KIF18B (Kinesin Family Members):** Many kinesins are involved in spindle formation and chromosome movement during mitosis. * **CENPA (Centromere Protein A):** A histone H3 variant specific to centromeres, crucial for kinetochore assembly and chromosome segregation. * **PBK (PDZ Binding Kinase):** Involved in cell cycle regulation and mitosis. * **DLGAP5 (DLG Associated Protein 5):** Involved in spindle organization and cytokinesis. * **ASPM (Abnormal Spindle Microtubule Assembly):** Essential for normal spindle function and cell division. * **CEP55 (Centrosomal Protein 55):** Involved in cytokinesis. * **FOXM1 (Forkhead Box M1):** A transcription factor that regulates the expression of many genes involved in cell cycle progression and mitosis. * **TK1 (Thymidine Kinase 1):** Involved in DNA synthesis, highly expressed in S-phase. * **RRM2 (Ribonucleotide Reductase M2):** Essential for DNA synthesis. * **PLK1 (Polo-like Kinase 1):** A key regulator of multiple mitotic events. * **CDC45, CDC25C, CDT1:** Cell division cycle proteins, crucial for DNA replication and cell cycle transitions. * **GINS2, RAD51AP1:** Involved in DNA replication and repair. The overwhelming majority of these markers are directly associated with the cell cycle, DNA replication, mitosis, and cell proliferation. There are no clear markers for specific mature immune cell types (e.g., CD3 for T cells, CD19 for B cells, CD14 for monocytes, CD16 for NK cells, CD68 for macrophages, CD1c for dendritic cells, etc.). **Step 2: Consider Biological Context** * **Tissue Type: Peripheral Blood (Human)**: Peripheral blood is a complex tissue containing various mature immune cells (T cells, B cells, NK cells, monocytes, granulocytes), as well as a small population of hematopoietic stem and progenitor cells (HSPCs) and circulating tumor cells (if present in disease states). * **Species: Human**: The gene names are standard human gene symbols. * **Biological Plausibility**: In healthy peripheral blood, mature immune cells are largely quiescent (non-proliferating). However, there are always a small number of circulating progenitor cells, and in certain physiological or pathological conditions (e.g., infection, inflammation, hematological malignancies), immune cells can become activated and proliferate, or immature/proliferating cells might be released into circulation. Given the strong proliferative signature, we must consider cell types that are actively dividing. **Step 3: Formulate Hypotheses** Based on the strong and consistent proliferative signature, I will formulate the following hypotheses: 1. **Hypothesis 1: Proliferating Cells (General)**: This cluster represents a population of cells that are actively undergoing cell division, regardless of their specific lineage. This is the most direct interpretation of the marker list. * *Likelihood:* Very High. The markers are unequivocally linked to proliferation. 2. **Hypothesis 2: Hematopoietic Stem and Progenitor Cells (HSPCs)**: HSPCs are inherently proliferative and reside in the bone marrow but can circulate in peripheral blood, especially after mobilization or in certain disease states. They are the source of all mature blood cells. * *Likelihood:* High. This is a plausible source of proliferating cells in peripheral blood. While specific HSPC markers (e.g., CD34, CD38,... [truncated]"